BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38624132)

  • 1. Can We Differentiate Between Primary Sjögren Syndrome and Idiopathic Multicentric Castleman Disease Based on the Characteristics of Pulmonary Cysts?
    Zhou J; Zhang L; Liu X; Zhang M; Liu Z; Jin Y; Feng R; Shi J; Li J; Zhang W
    J Thorac Imaging; 2024 Apr; ():. PubMed ID: 38624132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of Pulmonary Involvement in Idiopathic Multicentric Castleman Disease-Not Otherwise Specified: From Nodules to Cysts or Consolidation.
    Zhou J; Zhang L; Liu X; Zhang M; Li J; Zhang W
    Chest; 2023 Aug; 164(2):418-428. PubMed ID: 36963752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary Manifestations of Plasma Cell Type Idiopathic Multicentric Castleman Disease: A Clinicopathological Study in Comparison with IgG4-Related Disease.
    Nishimura MF; Igawa T; Gion Y; Tomita S; Inoue D; Izumozaki A; Ubara Y; Nishimura Y; Yoshino T; Sato Y
    J Pers Med; 2020 Dec; 10(4):. PubMed ID: 33321725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Predictive Model for Idiopathic Multicentric Castleman Disease: The International Castleman Disease Consortium Study.
    Yu L; Shi M; Cai Q; Strati P; Hagemeister F; Zhai Q; Li L; Fang X; Li J; Sun R; Zhang S; Yang H; Wang Z; Qian W; Iwaki N; Sato Y; Zhang L; Li J; Oksenhendler E; Xu-Monette ZY; Young KH
    Oncologist; 2020 Nov; 25(11):963-973. PubMed ID: 32852137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiological and Pathological Features of Cyst Formation in Idiopathic Multicentric Castleman Disease.
    Otoshi R; Sekine A; Muraoka T; Iwasawa T; Takemura T; Matsushita S; Okudela K; Kitamura H; Baba T; Ogura T
    Adv Respir Med; 2023 Apr; 91(2):164-173. PubMed ID: 37102781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloidosis and lymphoproliferative disease in Sjögren syndrome: thin-section computed tomography findings and histopathologic comparisons.
    Jeong YJ; Lee KS; Chung MP; Han J; Chung MJ; Kim KI; Seo JB; Franquet T
    J Comput Assist Tomogr; 2004; 28(6):776-81. PubMed ID: 15538150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of primary Sjögren's syndrome related lymphocytic interstitial pneumonia.
    Dong X; Gao YL; Lu Y; Zheng Y
    Clin Rheumatol; 2021 Feb; 40(2):601-612. PubMed ID: 32613392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathoracic multicentric Castleman disease: CT findings in 12 patients.
    Johkoh T; Müller NL; Ichikado K; Nishimoto N; Yoshizaki K; Honda O; Tomiyama N; Naitoh H; Nakamura H; Yamamoto S
    Radiology; 1998 Nov; 209(2):477-81. PubMed ID: 9807577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic multicentric Castleman disease treated with siltuximab for 15 years: a case report.
    Lang E; Sande B; Brodkin S; van Rhee F
    Ther Adv Hematol; 2022; 13():20406207221082552. PubMed ID: 35251585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of idiopathic multicentric Castleman disease with pulmonary hyalinizing granuloma-like multiple pulmonary nodules.
    Hatano H; Tsujimoto Y; Watanabe H; Tsukada A; Izumi S; Nagasaka S; Igari T; Suzuki M; Iikura M; Hojo M
    Respir Investig; 2023 Jul; 61(4):405-408. PubMed ID: 37099891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic multicentric Castleman disease and associated autoimmune and autoinflammatory conditions: practical guidance for diagnosis.
    González García A; Fernández-Martín J; Robles Marhuenda Á
    Rheumatology (Oxford); 2023 Apr; 62(4):1426-1435. PubMed ID: 35997567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic Plasmacytic Lymphadenopathy Forms an Independent Subtype of Idiopathic Multicentric Castleman Disease.
    Nishikori A; Nishimura MF; Nishimura Y; Otsuka F; Maehama K; Ohsawa K; Momose S; Nakamura N; Sato Y
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic multicentric Castleman disease with positive antiphospholipid antibody: atypical and undiagnosed autoimmune disease?
    Nishimura Y; Nishikori A; Sawada H; Czech T; Otsuka Y; Nishimura MF; Mizuno H; Sawa N; Momose S; Ohsawa K; Otsuka F; Sato Y
    J Clin Exp Hematop; 2022 Jun; 62(2):99-105. PubMed ID: 35249898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinical and pathological features of lung lesions of systemic IgG4-related disease and idiopathic multicentric Castleman's disease.
    Terasaki Y; Ikushima S; Matsui S; Hebisawa A; Ichimura Y; Izumi S; Ujita M; Arita M; Tomii K; Komase Y; Owan I; Kawamura T; Matsuzawa Y; Murakami M; Ishimoto H; Kimura H; Bando M; Nishimoto N; Kawabata Y; Fukuda Y; Ogura T;
    Histopathology; 2017 Jun; 70(7):1114-1124. PubMed ID: 28207938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic multicentric Castleman disease with pulmonary and cutaneous lesions treated with tocilizumab: A case report.
    Han PY; Chi HH; Su YT
    World J Clin Cases; 2020 Oct; 8(20):4922-4929. PubMed ID: 33195662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAFRO Syndrome: A Syndrome or a Subtype of Multicentric Castleman Disease?
    Takai K
    Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune-mediated thrombocytopenia and IL-6-mediated thrombocytosis observed in idiopathic multicentric Castleman disease.
    Rubenstein AI; Pierson SK; Shyamsundar S; Bustamante MS; Gonzalez MV; Milller ID; Brandstadter JD; Mumau MD; Fajgenbaum DC
    Br J Haematol; 2024 Mar; 204(3):921-930. PubMed ID: 38168727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary alveolar microlithiasis: CT and pathologic findings in 10 patients.
    Sumikawa H; Johkoh T; Tomiyama N; Hamada S; Koyama M; Tsubamoto M; Murai S; Inoue A; Nakamura H; Tachibana T; Müller NL
    Monaldi Arch Chest Dis; 2005 Mar; 63(1):59-64. PubMed ID: 16035566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic challenges of the idiopathic plasmacytic lymphadenopathy (IPL) subtype of idiopathic multicentric Castleman disease (iMCD): Factors to differentiate from IgG4-related disease.
    Nishikori A; Nishimura MF; Fajgenbaum DC; Nishimura Y; Maehama K; Haratake T; Tabata T; Kawano M; Nakamura N; Momose S; Sumiyoshi R; Koga T; Yamamoto H; van Rhee F; Kawakami A; Sato Y
    J Clin Pathol; 2024 Feb; ():. PubMed ID: 38378248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAFRO Syndrome and Elusive Diagnosis of Idiopathic Multicentric Castleman Disease Treated with Empiric Anti-Interleukin-6 Therapy.
    Williams C; Phillips A; Aggarwal V; Slonim LB; Fajgenbaum DC; Karmali R
    Case Rep Oncol; 2021; 14(3):1359-1365. PubMed ID: 34720942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.